Species |
Cynomolgus |
Protein Construction |
CD73/NT5E (Trp27-Cys554) Accession # EHH53214.1 |
His |
N-term |
C-term |
|
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus CD73, His Tag at 2μg/ml (100μl/Well) on the plate can bind AntiCD73 Antibody, hFc Tag. Test result was comparable to standard batch. Measured by its ability to hydrolyze the 5'phosphate group from the substrate adenosine5'monophosphate (AMP). The specific activity is > 10000 pmol/min/μg. Test result meets the standard. |
Expression System |
HEK293 |
Theoretical Molecular Weight |
59.6 kDa |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from 0.22μm filtered solution in 20mM Tris, 120mM NaCl (pH 7.5). |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Target Background |
CD73, also known as ecto-5'-nucleotidase, is an enzyme that in humans is encoded by the NT5E gene.CD73 commonly serves to convert AMP to adenosine.The enzyme consists of a dimer of 2 identical 70-kD subunits bound by a glycosyl phosphatidyl inositol linkage to the external face of the plasma membrane. The enzyme is used as a marker of lymphocyte differentiation. A deficiency of CD73 occurs in a variety of immunodeficiency diseases. |
Synonyms |
CD73; NT5E; NTE; 5' nucleotidase (CD73); 5'-NT; 5-NT; E5NT; EC 3.1.3.5; eN; eNT; NT; NT55'-nucleotidase; NT5; NTE; CALJA |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.